NRXP (NRx Pharmaceuticals, Inc.) Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan

High R&D expenditures in psychiatry keep the operating leverage of NRx Pharmaceuticals (NRXP) in negative territory. NRx Pharmaceuticals (NRXP) is optimizing the supply of psychotropic drugs through diversified distribution channels to protect margins. This price chart reflects a value of 0.00, while the business relies on developing agents that target NMDA receptors, focusing on therapy reimbursement by insurance companies and clinics.

NRXP (NRx Pharmaceuticals Inc.) riwayat Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan saka 23.11.2025 nganti 15.11.2026

Rincian metrik komprehensif lan analitis NRx Pharmaceuticals Inc. (NRXP)

- rega pasar lan target rega analis:

Bagan rega NRx Pharma|NRXP - Bagan tingkat prakiraan

- indikator valuasi pasar bisnis:

Nilai pasar NRx Pharma|NRXP - Rega Tumbas Perusahaan

- indikator nilai buku ekuitas:

Nilai Akuntansi saben Saham NRx Pharmaceuticals|NRXP - Ekuitas Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku nrxpharma.com|NRXP - Gunggung Aset Perusahaan

- data liabilitas lan likuiditas perusahaan:

Total Utang marang Modal NRx Pharmaceuticals|NRXP - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas nrxpharma.com|NRXP - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku NRx Pharma|NRXP - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan NRx Pharmaceuticals|Indikator likuiditas cepet nrxpharma.com

- indikator pendapatan resik lan kelipatan nilai:

NRXP - Bathi perusahaan|Bathi mangsa ngarep NRx Pharmaceuticals|NRXP - Nilai perusahaan marang bathi resik|Rega marang bathi mangsa ngarep NRx Pharmaceuticals|NRXP - Rasio kapitalisasi marang bathi lan wutah|Pangali EV/EBITDA NRx Pharmaceuticals Inc.|NRXP - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) NRx Pharmaceuticals|NRXP - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan nrxpharma.com|NRXP - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep NRx Pharmaceuticals

- rincian pendapatan lan dodolan:

NRXP - Dodolan perusahaan|Prakiraan volume dodolan NRx Pharmaceuticals, Inc|NRXP - Multiplikator P/S|Multiplikator Forward P/S NRx Pharmaceuticals Inc.|NRXP - Wutah pendapatan YoY sajrone 12 wulan kepungkur

Analisis wiwitan perusahaan:NRXP (NRx Pharmaceuticals, Inc.)

NRx Pharmaceuticals' ability to withstand market downturns currently depends on the effectiveness of the management's restructuring course to stabilize liquidity. The business's EV/EBITDA metric, which has reached 0.00, compares the total enterprise value with operating profit, allowing investors to assess the real value of assets net of debt and determine the company's level of debt risk.

Analisis pesaing NRx Pharmaceuticals